Olamkicept clinical trials
Also written FE 999301.
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2018
How each study uses olamkicept is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- FE 999301
- 2
Studies by the year they started
3 studies that test it; most in 2024 (2)
| Year | Studies |
|---|---|
| 2018 | 1 |
| 2024 | 2 |
Who runs them
Industry 3 · Other 0
Ferring Pharmaceuticals (2) · I-Mab Biopharma HongKong Limited (1)
Studies
Open first, then newest update. How each study uses olamkicept is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Investigating the Safety, Tolerability, Immunogenicity and Pharmacokinetics of Olamkicept in Healthy Japanese PersonsCompletedPhase 1Ferring PharmaceuticalsNCT06515834Written as FE 999301How we know
- A Study Investigating the Safety, Tolerability, Immunogenicity and Pharmacokinetics of Olamkicept in Healthy PersonsCompletedPhase 1Ferring PharmaceuticalsNCT06298032Written as Olamkicept Part AHow we know
- Safety and Efficacy of TJ301 IV in Participants With Active Ulcerative ColitisCompletedPhase 2I-Mab Biopharma HongKong LimitedNCT03235752Written as TJ301 300mgHow we know
Codes
What other systems call olamkicept · ClinicalTrials.gg INT005084
- MeSH (NLM) C519852olamkiceptOne source NLM
- UNII (FDA) ZW1H7GZO9WOLAMKICEPTConfirmed FDA, NLM
- NCI Thesaurus C174956OlamkiceptOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C519852 | olamkicept | One source NLM |
| UNII (FDA) | ZW1H7GZO9W | OLAMKICEPT | Confirmed FDA, NLM |
| NCI Thesaurus | C174956 | Olamkicept | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.